“Enabling and accelerating Africa’s contribution to the development of the world’s future medicines. Becoming the CRO of choice for the pan-African sub-region, recognized for a quality-focused, technology-led range of research solutions with patients at its heart.”
Creating an environment where Africans lead the change in research, data gathering, and managing programs benefiting local populations.
Ultimately, we want Africa’s contribution to the world of medicine to faithfully represent the diversity of the populations we serve.
We understand the challenges of clinical research and are committed to delivering customized solutions that meet our clients’ specific needs. Our expertise in clinical trial management ensures that we can successfully design, plan, and execute trials that meet regulatory requirements, timelines, and budgets. We provide support throughout the entire clinical trial process, from site selection to study closeout, and everything in between.
Advanced healthcare systems are slowly becoming the norm in Africa as the economy and the financial prospects of Africans improve, subsequently Africans seek to be at the forefront of medical advances. With this drive for better, more targeted medicines and medical technologies it is important for the pharmaceutical industry to pay attention to this important emerging market.
Africa Clinical Trial Solutions (ACTS) is a Contract Research Organisation founded by a pharmaceutical industry expert, and backed by a network of professionals, supports pharmaceutical companies, NGOs, and research institutions in launching top-notch medicines, medical devices and diagnostic tools.
At Africa-CTS we seek to assist pharmaceutical companies, NGOs and research institutions to achieve clinical research excellence, in order to successfully launch gold-standard medicines and technologies.
We aim to provide clinical trial solutions to high ethical standards, reduced timelines and costs, with patient/healthy volunteer safety at the core.
Managing Director.
Milena Kanova, MD
20 years CRO, including emerging markets; 5 years Pharma and Biotech
James Cornwall, PhD
30 years in pharma, CRO, biotech, venture capital in established and emerging markets